GGrantIndex
← Leaderboards

Hans Schreiber

University Of Chicago

Google Scholar ↗PubMed ↗ORCID ↗
$12,391,832
Attributed
$12,391,832
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY2005–24
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$28,695,024 · 9

By mechanism

P01$18,729,752 · 5
R01$9,379,602 · 2
T32$375,670 · 1
S10$210,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “T-Lymphocyte”

Research focus

T-LymphocyteTumorMalignant NeoplasmsAntigensTumor AntigensCancer CellSolid NeoplasmPreventMutantVariantCd8b1 GeneCellsSuccessImmunotherapyTumor GrowthAnimalsAdoptive TransferSolidEventOptic ImagingGrowthGenesRelapseIn Vivo

Grant awards (62)

Manipulation of Tumor Specific Immunity$316,778
R01 · FY2024 · CA · contact PI
Manipulation of Tumor Specific Immunity$333,450
R01 · FY2023 · CA · contact PI
Manipulation of Tumor Specific Immunity$326,781
R01 · FY2022 · CA · contact PI
Manipulation of Tumor Specific Immunity$333,450
R01 · FY2021 · CA · contact PI
Manipulation of Tumor Specific Immunity$348,950
R01 · FY2020 · CA · contact PI
Manipulation of Tumor Specific Immunity$279,675
R01 · FY2019 · CA · contact PI
Manipulation of Tumor Specific Immunity$288,325
R01 · FY2018 · CA · contact PI
Manipulation of Tumor Specific Immunity$288,325
R01 · FY2017 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$231,385
R01 · FY2017 · CA · contact PI
Manipulation of Tumor Specific Immunity$288,325
R01 · FY2016 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$231,385
R01 · FY2016 · CA · contact PI
Manipulation of Tumor Specific Immunity$302,825
R01 · FY2015 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$231,385
R01 · FY2015 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$224,443
R01 · FY2014 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$260,385
R01 · FY2013 · CA · contact PI
Manipulation of Tumor Specific Immunity$243,389
R01 · FY2013 · CA · contact PI
CD8+ T cells and Immunological Tumor Regression$1,481,141
P01 · FY2012 · CA · contact PI
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T$280,641
P01 · FY2012 · CA · contact PI
Manipulation of Tumor Specific Immunity$258,924
R01 · FY2012 · CA · contact PI
Administrative/Statistics/Imaging Core$111,371
P01 · FY2012 · CA · contact PI
CD8+ T cells and Immunological Tumor Regression$1,513,695
P01 · FY2011 · CA · contact PI
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T$278,326
P01 · FY2011 · CA · contact PI
Manipulation of Tumor Specific Immunity$258,853
R01 · FY2011 · CA · contact PI
Administrative/Statistics/Imaging Core$115,348
P01 · FY2011 · CA · contact PI
CD8+ T cells and Immunological Tumor Regression$1,551,333
P01 · FY2010 · CA · contact PI
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T$287,509
P01 · FY2010 · CA · contact PI
Manipulation of Tumor Specific Immunity$266,640
R01 · FY2010 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$235,523
R01 · FY2010 · CA · contact PI
Administrative/Statistics/Imaging Core$121,265
P01 · FY2010 · CA · contact PI
CD8+ T cells and Immunological Tumor Regression$1,493,912
P01 · FY2009 · CA · contact PI
Manipulation of Tumor Specific Immunity$294,566
R01 · FY2009 · CA · contact PI
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T$283,766
P01 · FY2009 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$235,523
R01 · FY2009 · CA · contact PI
Administrative/Statistics/Imaging Core$121,675
P01 · FY2009 · CA · contact PI
CD8+ T cells and Immunological Tumor Regression$1,543,335
P01 · FY2008 · CA · contact PI
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T$293,329
P01 · FY2008 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$235,523
R01 · FY2008 · CA · contact PI
Administrative/Statistics/Imaging Core$128,060
P01 · FY2008 · CA · contact PI
CD8+ T Cells and Immunological Tumor Regression$1,514,024
P01 · FY2007 · CA · contact PI
Manipulation of Tumor Specific Immunity$253,046
R01 · FY2007 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$238,247
R01 · FY2007 · CA · contact PI
CD8+ T Cells and Immunological Tumor Regression$1,517,273
P01 · FY2006 · CA · contact PI
Manipulation of Tumor Specific Immunity$381,652
R01 · FY2006 · CA · contact PI
Immunology of Unique Tumor Specific Antigens$252,441
R01 · FY2006 · CA · contact PI
CD8+ T Cells and Immunological Tumor Regression$1,512,066
P01 · FY2005 · CA
Manipulation of Tumor Specific Immunity$401,733
R01 · FY2005 · CA
IMMUNOLOGY OF UNIQUE TUMOR SPECIFIC ANTIGENS$22,875
R01 · FY2005 · CA
CD8+ T Cells and Immunological Tumor Regression$1,468,509
P01 · FY2004 · CA
Manipulation of Tumor Specific Immunity$266,875
R01 · FY2004 · CA
CD8+ T Cells and Immunological Tumor Regression$1,438,871
P01 · FY2003 · CA
Manipulation of Tumor Specific Immunity$266,875
R01 · FY2003 · CA
Three Laser BD Digital LSR$210,000
S10 · FY2003 · RR
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY$375,670
T32 · FY2002 · AI
IMMUNOLOGY OF UNIQUE TUMOR SPECIFIC ANTIGENS$234,839
R01 · FY2002 · CA
MANIPULATION OF TUMOR SPECIFIC IMMUNITY$91,320
R01 · FY2002 · CA
TRANSFORMING GENES AND IMMUNOLOGICAL TUMOR REGRESSION$644,708
P01 · FY2001 · CA
"UNIQUE" TUMOR ANTIGENS RECOGNIZED BY CD8+ T CELLS$254,104
P01 · FY2001 · CA
IMMUNOLOGY OF UNIQUE TUMOR SPECIFIC ANTIGENS$229,143
R01 · FY2001 · CA
TRANSFORMING GENES AND IMMUNOLOGICAL TUMOR REGRESSION$624,325
P01 · FY2000 · CA
IMMUNOLOGY OF UNIQUE TUMOR SPECIFIC ANTIGENS$223,065
R01 · FY2000 · CA
MANIPULATION OF TUMOR SPECIFIC IMMUNITY$202,683
R01 · FY2000 · CA
"UNIQUE" TUMOR ANTIGENS RECOGNIZED BY CD8+ T CELLS$151,166
P01 · FY2000 · CA